PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Literature review. Urology 2001
Article published in Urologia Polska 2002/55/1.

authors

Andrzej Borkowski, Tomasz Borkowski

references

  1. 1. Andrich DE, Mundy AR, The nature of urethral injury in cases of pelvic fracture urethral trauma. JUrol 2001; 165:1492-1495.
  2. 2. Hughes ODM, Perkins AC, Frier M i wsp. Imaging for staging bladder cancer: a clinical study of intravenous 111 indium-labelled anti-MUCl mucin monoclonal antibody C595. BJU International 2001; 87: 39-46.
  3. 3. Rorvik J, Haukaas S. Magnetic imaging of the prostate. Current Opinion in Urology 2001; 11:181-188.
  4. 4. Ogura K, Maekawa S, Okubo K i wsp: Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer; correlation with histopatological results. Urology 2001; 57: 721-726.
  5. 5. Jung P, Brauers CA, Nolte-Ernsting CA i wsp: Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction. BJU International 2000; 86: 960-965.
  6. 6. James DD, Tblley DA. Virtual endoscopy in urology. Current Opinion in Urology 2001; 11:189-192.
  7. 7. Tsushima Y, Blomley MJK, Okabe K i wsp: Determination of glomerular filtration rate per unit renal volume using computerized tomography: correlation with conventional measures of total and divided renal function. J Urol 2001; 165,382-385.
  8. 8. Konety BR, Getzenberg RH: Urine based markers of urinary malignancy. J Urol 2001; 165: 600-611.
  9. 9. Golijanin D, Shapiro A, Pode D: Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer. J Urol 2000; 164: 1922-1925.
  10. 10. Hailing KC, King W, Sokolova IA i wsp: A comparison of cytology andfluorescsnce in situ hybridization for the detection of urothelial carcinoma. J Urol 2000; 164: 1768-1775.
  11. 11. Bernardini S, Billerey C, Martin M. i wsp: The predictive value ofmuscularis mucosae invasion andp53 over expression on progression of stage Tl bladde carcinoma. J Urol; 2001:165: 42-46.
  12. 12. Byrne RR, Shariat SF, Brown R. i wsp: E-Cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long term followup. J Urol 2001; 165:1473-1479.
  13. 13. Saint F, Patard JJ, Irani J. i wsp: Leucocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer. Urology 2001; 57:617-622.
  14. 14. Thalmann GN, Sermier A, Rentsch C. i wsp: Urinary interkuki-n-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin. J Urol 2000; 164: 2129-2133.
  15. 15. O\\\' Donnell MA, Khron J. DeWolf WC: Salvage intravesical therapy with interferon alfa 2B plus low dose Bacillus Calmette-Guerin is effective in patients with superficial bladder cancer in whom Bacillus Calmette-Guerin alone previously failed. J Urol 2001; 166:1300-1305.
  16. 16. Herr HW. Sogani PC: Does early cystectomy improve the survival of patients with high risk superficial bladder tumors. J Urol 2001; 166: 1296-1299.
  17. 17. Leibovici D, Zisman A, Chen-Levyi Z. i wsp: Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmettte-Guerin. J Urol 2000; 164:1546-1549.
  18. 18. Herr HW, Donat M. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node disssecion and radical cystectomy. J Urol 2001; 165: 62-64.
  19. 19. Retz M, Lehmann J, Trocha Ch. i wsp: Long terrm follow-up of combined radiochemotherapy for locally advanced bladder carcinoma. Cancer 2000; 89:1089-94.
  20. 20. Von der Maase H, Hansen SW, Dogliotti L. i wsp: Gemcitabine and Cisplatin versus Metotrexate, Vinblastine, Doxorubicin and Cisplatin in advanced or metastaciic bladder cancer; results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 17: 3068-3077.
  21. 21. Herr HW: Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 2001; 19: 89-93.
  22. 22. Zietman AL. Grocela J, Zehr E. i wsp: Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, Tl, and Tis recurrence within the retained bladder. Urology 2001; 58: 380-385,
  23. 23. deVere White R. Evans ChP. Lara PN. i wsp: Improving the treatment of muscle invasive transitional cell carcinoma (TCC) of the bladder with sequential approach. Uro Oncology 2001; 1: 175-183.
  24. 24. Weinstein RP, Grób BM. Pachter EM. i wsp; Partial cystectomy during radical surgery for nonuroiogical malignancy. J Urol 2001; 166: 79-81.
  25. 25. Rukstalis DB, Khorsandi M, Garcia FU. i wsp: Clinical experience with open renal cryoablation. Urology 2001; 57: 34-39.
  26. 26. McClellan M, Walther M. Linehan WM: Percutaneous radio frequency ablation of small renal tumors. AUANews 2001 September/October; 9: str. 16 i 22.
  27. 27. Gettman MT. Bishoff JT. Su LM. i wsp: Hemostatic laparoscopic partial nephrectomy: initial experience with the radiofrequen-cy coagulation-assisted technique. Urology 2001; 58: 8-11.
  28. 28. Parsons JK, Schoenberg MS, Carter HB: Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology 2001; 57: 1013-1015.
  29. 29. Aki FT, Bilen C Y, Tekin MI. i wsp: Is scrotal violation per se risk factor for local relapse and metastases in stage I nonseminomato-us testicular cancer. Urology 2000; 56: 459-462.
  30. 30. Schroder F, Roobol-Bouts M, Vis AN. i wsp: Prostate-specific antigen-based early detection of prostate cancer - validation of screening without rectal examination. Urology 2001; 57: 83-90.
  31. 31. Mitchell IDC, Crroal BL, Dickie N. i wsp: A prospective study to evaluate the role of complexed prostate specific antigen and freeltotal prostate specific antigen ratio for diagnosis of prostate cancer. J Urol 2001; 165: 1549-1553.
  32. 32. Okihara K, Fritsche HA, Ayala A. i wsp: Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total specific antigen between 2.5 and 4.0 nglml J Urol 2001; 165: 1930-1936,
  33. 33. Chen ME, Johnston DA, Tang K. i wsp: Detailed mapping of prostate foci. Cancer 2000; 89: 1800-1809.
  34. 34. Post PN, Hansen BE, Kil PJM. i wsp: The independent prognostic vvalue of comorbidity among men aged < 75 years with localised prostate cancer: a population-based study. BJU International 2001; 87: 821-826.
  35. 35. Shall O, Mclamed J, Lepor H: Analysis of apical soft tissue margins during retropubic radical prostatectomy. J Urol 2001; 165: 1943-1949.
  36. 36. Noldus J, Michl U, Graelen M i wsp: Die nerverhaltende radi-kale retropubische prostatektomie. Urologe[A] 2001; 40: 102-106.
  37. 37. Sakr WA, Telilli MV, Grignon DJ, i wsp: Gleason score 7prostate cancer: a heterogenou entity? Correlation with pathologic parameters and disease-free survival. Urology 2000; 56: 730-734.
  38. 38. Roberts WW, Bergstralh EJ, Blule MJ. I wsp: Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 2001; 57: 1033-1037.
  39. 39. Blute ML, Bergstralh, locca A: Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 2001; 165: 119-125.
  40. 40. Ross PL, Scardino PT, Kattan MW: A catalog of prostate cancer nomogiamms. J Urol 2001,165,1562-1568.
  41. 41. Schulmann CC, Altwein JE, Zlotta AR: Treatment options after failure of local curative treatments in prostate cancer: a controversial issue. BJU International 2000; 86: 1014-1022.
  42. 42. Leventis KA. Shariat SF. Kattan MW. i wsp: Prediction of response to salvage radiation therapy with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2001; 19:1030-1039.
  43. 43. Yurkanin JP, DalkinBL, Cui H: Evaluation of cold knife urethrotomy for the treatment of anastomotic stricture after radical retropubic prostatectomy. J Urol 2001; 165: 1545-1548.
  44. 44. Pollack A, Zagars GK, Smith LG: Preliminary results of a randomized radiotherapy dose-escaalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 2000; 18: 3904-3911.
  45. 45. Anderson PR. Hanlon AL. Horowitz E. i wsp: Outcome and predictive factors for patients with Gleason score 7 prostate cancer treated with three-dimensional conformal external beam radiation therapy. Cancer 2000; 89: 2565-9.
  46. 46. Schellhammer PF, Moriarty R, Bostwick D. i wsp: Fiftteen -year minimum follow-up of a prostatic brachyterapy series: comparing the past with the present. Urology 2000; 56: 436-441.
  47. 47. Koizumi M, Yonnese J, Fukui I. i wsp: 77?^ serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone. BJU International 2001; 87: 384-351.
  48. 48. Tomera K, Gleason D, Gittclman M. i wsp: The gonadotropin--releasing hornwne antagonist Abarelix depot versus luteinizinghormone releasing hoimone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer. J Urol 2001; 165:1585-1589.
  49. 49. Palmberg C, Koivisto P, Kakkkola R. i wsp: Androgen receptor gene amplificattiion at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer. J Urol 2000; 164: 1992-1995.
  50. 50. Klotz L: Combined androgen blockade in prostate cancer: meta--analyses and associated issues. BJU International 2001; 87: 806-813.
  51. 51. Schmitt B, Wilt TJ, Schellhamer PF. i wsp: Combined androgen blockade with nonsteroidal anliandrogens for advanced prostate cancer: a systematic review. Urology 2001; 57: 727-732.
  52. 52. Kaplan S, Garvin D, Gilhooly P. i wsp: Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-reiated outcomes and long-term response to finasteride. Urology 2000; 56:610-616.
  53. 53. Marberger MJ, Andersen JT, Nickel JC. i wsp: Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. EurUrol 2000; 38: 563-568.
  54. 54. Yang Q, Peters TJ, Donovan JL. i wsp: Transurethral incision compared with transurethral resection of the prostate for bladder outlet obslivction: a systematic review and meta-analysis of randomized controlled trials. J Urol 2001; 165: 1526-1532.
  55. 55. Hakenberg OW, Helke Ch, Mansek A. i wsp: Is there a relationship between the amonunt of tissue removed at transurethral resection of the prostate and clinical improvement in benign prostatic hyperplasia. Eur Urol 200; 39: 412-417.
  56. 56. Han SW, Maizcls M, Chou PM. i wsp: Lamina muscularis propria thickness of renal pelvis predicts radiological outcome of surgical correction of ureteropelvic junction obstruction. J Urol 2001; 165: 1648-1651.
  57. 57. Speziale F, Sbarigia E, Grossi R. i wsp: Inflammatory aneurysms of the abdominal aorta involving the ureters: is combined treatment really necessary. J Urol 2001; 165: 27-31.
  58. 58. Miyajima A, Asano T, Asano T. i wsp: Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 2001; 165: 1714-1718.
  59. 59. Thompson A, Gough DCS: The use of renal scintigraphy in assessing the potential for recovery in the obstructed renal tract in children. BJU International 2001; 87: 853-856.
  60. 60. Nickel JC, True LD, Krieger JN. i wsp: Consensus development of a histopathological classification system for chronic prostatic inflammation RlUInternationa! 2001; 87: 797-805.
  61. 61. Dimitrakov J, Diemer T, Ludwig M. i wsp: Recent developments in diagnosis and therapy of the prostatitis syndromes. Curr Opin Urol 2001; 11: 87-91. \\\'
  62. 62. Wagenlehner FME, Naber KG. Uncomplicated urinary trad infections in women Curr Opin Urol 2001; 11: 49-53.
  63. 63. Hemal AK, GuptaNP, Rajeev TP. i wsp: Polymerase chain reaction in clinically suspected genitourinary tuberculosis: comparison with intravenous urography, bladder biopsy and urine acid fast bacilli culture. Urology 2000; 56: 570-574.
  64. 64. Abrams IMP, Cardozo L, Roberts RG. i wsp: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU International 2001; 87: 760-766.
  65. 65. Thilagarajah R, O\\\'N Withcrow R, Walker MM: Oral cimetidi-ne gives effective symptom relief in painful bladder disease: a pro-speclve, randomized, double-blind placebo-controlled trial. BJU International 2001; 87: 207-212.
  66. 66. Hugonnet C, Danuscr H, Springer JP. i wsp: Diminution cle la sensibilite au niveau de 1\\\'uretre membraneux aprcs vessie ileale orthotopique de substitution. Progres en Urologie 2001; 11: 245-249.
  67. 67. Phelan MW, FranksM, Somogyi GT i wsp: Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001; 165: 1107-1110.
  68. 68. Appcll R. Aigumenl for sling surgery to replace bladder suspension for stress urinary incontinence. Urology 2000; 56: 360-363.
  69. 69. Yonneau L, Charlier-Kastler E, Bohin D. i wsp: Les materiaux utitisables dans les traitement de I\\\'incontinence urinaire d\\\'effort par bandelette sous urethro-cervicale. Progres en Urologie 2000; 10: 1238-1244.
  70. 70. Choe JM, Bell T: Genetic material is present in cadaveric dermis and cadaveric fascia lata. J Urol 2001; 166: 122-124.
  71. 71. Erickson DR: Editorial: female stress incontinence. J Urol 2001; 165: 1612-1613.
  72. 72. Costa P, Mottet N, Rabut B. i wsp: The use of an artificial urinary sphincter in women with type III incontinence and a negative Marshall test. J Urol 2001; 165: 1172-1176.
  73. 73. Montague DK. Angermeier KW. Paolonc DR: Long-term continence and patient satisfaction after artificial sphincter implantation for urinary incontinence after prostatectomy. J Urol 2001; 166: 547-549.
  74. 74. Elliott DS, Barrett DM, Gohma M. i wsp: Does nocturnal deactivation of the artificial urinary sphincter lessen the risk of urethral atrophy? Urology 2001; 57: 1051-1054.
  75. 75. Walsh PC: Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology 2000; 57:1020-1024.
  76. 76. Chahal R, Gogol NK, Sundaram SK. i wsp: Corporal plication for penile curvature caused by Peyronie\\\' s disease: the patients\\\' perspective. BJU International 2001; 87: 352-356.
  77. 77. Perovic SV, Djordjevic MLJ: Penile lengthening. BJU International 2000; 86: 1028-1033.
  78. 78. Portillo FJM, Boehm-Hoang J, Weiss J. i wsp: Methylene blue as a successful treatment alternative for phaimacologically induced priapism. Eur Urol 2001; 39: 20-23
  79. 79. Sommer F. Schwarzer U. Klotz T. i wsp: Erectile dysfunction in cyclists. Eur Urol 2001; 39: 720- 723.
  80. 80. Harmon WJ, Kavoussi LR, Bishoff JT: Laparoscopic nephron--sparing surgery for solid renal masses using the ultrasonic shears. Urology 2000; 56: 754-759
  81. 81. Landman J, Lento P, Hassen W. i wsp: Feasibility of pathological evaluation of morcellated kidneys after radical nephrectomy. J Urol 2000; 164: 2086-2089.
  82. 82. Gill IS, Novick AC, Meraney AM. i wsp: Laparoscopic renal cryoablation in 32 patients. Urology 2000; 56: 784-753.
  83. 83. Baker LA, Docimo SG, Surer I. i wsp: A multi-institutional analysis of laparoscopic orchidopexy. BJU International 2000; 87, 484-489.
  84. 84. Rabil R, Salomom R, Saint t\\\', i wsp: Traitment des pheochromo-cytomes par laparoscopic retropeiitoneale. Progres en Urologie 2001; 11: 16-21.
  85. 85. Turk I, Deger S, Winkclmann B. i wsp: Laparoscopic radical cystectomy with continent urinary diversion (rectal sigmoid pouch) petformed completely intracorpooreally: the initial 5 cases. J Urol 2001; 165: 1863-186\\\'ć.
  86. 86. Guillonneau B, Cappele O, Bosco J. i wsp: Robotic assisted, laparoscopic pelvic lymph node dissection in humans. J Urol 2001; 165:1078-1081.
  87. 87. Gill IS, Sung GT, Hsu THS. i wsp: Robotic emote laparoscopic nephecttomy and adrenalectomy: the initial experience. J Urol 2000; 164: 2082-2085.
  88. 88. Abol-Enein H, Ghoneim MA: Functional results of orthotopic ileal neobladder with serous-lined extramural ureteral reimplantation: experience with 450 patients. J Urol 2001; 165: 1427-1432.
  89. 89. NetherclilTe J, Trewickk A, Samuell C. i wsp: False-positive tests in patients with enterocysloplasties. BJU International 2001; 87: 780-782.
  90. 90. Kavanagh JP: A critical appraisal of the hypotesis that urine is a saturated equilibrum with respect to stone-forming calcium salts. BJU International 2001; 87: 589-598.
  91. 91. Cooper JT, Stack GM, Cooper TP: Intensive medical management of ureteral calculi. Urology 2000; 56: 575-578.
  92. 92. Mokhmalji H, Braun PM, MartinezPortillo FJ. i wsp: Percutaneous nephrostomy versus ureteral stensfor diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial. JUrol 2001; 165: 1088-1092.
  93. 93. Feng MI, Tamaddon K, Mikhail A i wsp: Prospective randomized study of various techniques of percutaneous nephrolithotomy. Urology 2001; 58: 345-350.
  94. 94. Danauser H, Hochreiter WW, Ackerman DK: Influence of stent size on the succes of antegrade endopyelotomy for primary ureieropelvic junction obstruction: results of 2 consecutive series. J Urol 2001; 166:902-909.
  95. 95. Dreller SP: The stone cone: a new generation of basketry. J Urol 2001; 165: 1593-1596.
  96. 96. Rassweiler JJ, Rennner Ch, Caussy Ch. i wsp: Treatment of renal stones by extracorporeal Shockwave lithotripsy. Eur Urol 2001; 39: 187-199.
  97. 97. Hatch DA, KoyleMA, Baskin LS. i wsp: Kidney transplantation in children with urinary diversion or bladder augmentation. J Urol 2001; 165: 2265-2268.
  98. 98. Kukrcja RA, Desai RM, SabnisRB i wsp: The urethral instillation of depilatory cream for hair removal after scrotal flap urethroplasty. BJU International 2001; 87: 708-709.
  99. 99. Schneider T, Sperling H, Lummen G. i wsp: Urethrotomia interna nach Sachhse. Urologe [A] 2001; 40: 38-41.
  100. 100. Andrich DE, Leach CJ, Mundy AR: The Barbagliprocedure gives the best results for patch urethroplasty of the bulbar urethra. BJU International 2001; 88: 385-389.